20078 ⎘
Medicinal preparations characterised by special physical form; Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles; Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
DRUG DELIVERY SYSTEM
#2TOPICAL POWDER VEHICLE FOR THE TREATMENT OF ALOPECIA
#3EDIBLE PLANT-DERIVED NANOPARTICLES FOR REGULATION OF GUT MICROBIOTA
#4METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR
#5USE OF MILK EXOSOME IN PREPARATION OF DRUG CARRIER
#6Membrane Encapsulated Nanoparticles and Method of Use
#7Membrane Encapsulated Nanoparticles and Method of Use
#8Membrane Encapsulated Nanoparticles and Method of Use
#9METHOD OF TREATING CANCER
#10Method of treating conditions related to the PGI2 receptor
#11Solid Solution Compositions and Use in Chronic Inflammation
#12Membrane Encapsulated Nanoparticles and Method of Use
#13COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS
#14USE OF CELLULAR MICROPARTICLES IN TREATMENT OF RESPIRATORY VIRAL PNEUMONIA
#15INTRAVAGINAL FORMULATION
#16Fortified CBD oil for treatment of PTSD
#17CURCUMINOID COMPOSITES
#18SOLID SOLUTION MADE FROM GUM ARABIC AND AT LEAST ONE LIPOSOLUBLE ACTIVE SUBSTANCE
#19MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#20METHOD OF TREATING CONDITIONS RELATED TO THE PGI2 RECEPTOR
#21A stabilized protein of interest.
#22Compositions and methods for the treatment and prophylaxis of surgical site infections
#23PEPTIDE VACCINE BASED ON A NEW UNIVERSAL INFLUENZA A HEMAGGLUTININ HEAD DOMAIN EPITOPE AND HUMAN MONOCLONAL ANTIBODIES BINDING THERETO
#24Method of treating conditions related to the PGI2 receptor
#25CURCUMIN COMPLEX, PREPARATION METHOD THEREFOR AND DETECTION METHOD THEREFOR
#26MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
#27METHODS AND COMPOSITIONS FOR USE IN TREATMENT OF CANCER WITHOUT PSYCHOACTIVE EFFECTS
#28CANNABINOID COMPOSITION AND PROCESSES OF MANUFACTURE
#29Fortified CBD oil for treatment of PTSD
#30Solid solution compositions and use in chronic inflammation
#31Composition and/or combination for aquaculture
#32Curcuminoid composites
#33Method of treating conditions related to the PGI2 receptor
#34A CELLULAR SOLID MATERIAL DRUG CARRIER COMPRISING CELLULOSE NANOFIBERS (CNF) WHEREIN THE CELLULAR SOLID MATERIAL COMPRISES CLOSED CELLS
#35DRUG DELIVERY SYSTEM
#36Edible plant-derived nanoparticles for regulation of gut microbiota
#37Intravaginal formulation
#38Composition of heat-killed yeast and taurine or a phytomedicine for the treatment of chronic inflammation
#39ABUSE-DETERRENT DRUG FORMULATIONS
#40CANNABINOID COMPOSITION AND PROCESSES OF MANUFACTURE
#41Mixed allergen compositions and methods for using the same
#42Solid solution compositions and use in chronic inflammation
#43Method of treating conditions related to the PGI2 receptor
#44Compositions and methods for the treatment and prophylaxis of surgical site infections
#45TESTOSTERONE UNDECANOATE COMPOSITIONS
#46Mixed allergen compositions and methods for using the same
#47ABUSE-DETERRENT DRUG FORMULATIONS
#48Fortified CBD oil for treatment of PTSD
#49Mixed allergen compositions and methods for using the same
#50Food and beverage compositions infused with lipophilic active agents and methods of use thereof
#51Synergistic curcuminoids and probiotic compositions
#52Solid solution compositions and use in chronic inflammation
#53Herbo-mineral formulation for the treatment of cardio vascular diseases and method of preparation thereof
#54SYSTEM AND APPLIANCE FOR EXTENDING THE PRODUCTION OF NITRIC OXIDE BY SPINACH EXTRACT MICROENCAPSULATED POWDER AND ACIDIC GEL
#55Mixed allergen compositions and methods for using the same
#56Mixed allergen compositions and methods for using the same
#57Suspension compositions of physiologically active phenolic compounds and methods of making and using the same
#58Food and beverage compositions infused with lipophilic active agents and methods of use thereof
#59Food and beverage compositions infused with lipophilic active agents and methods of use thereof
#60Particulate delivery systems
#61HERBO-MINERAL FORMULATION FOR THE TREATMENT OF CARDIO VASCULAR DISEASES AND METHOD OF PREPARATION THEREOF
#62Method of treating conditions related to the PGI2 receptor
#63METHODS AND COMPOSITIONS FOR PRODUCTION OF RECOMBINANT PHARMACEUTICAL PROTEINS IN MEDICINAL PLANTS
#64Sustained Release Cannabinoid Formulations
#65Lipid formulations containing bioactive fatty acids
#66Food and beverage compositions infused with lipophilic active agents and methods of use thereof
#67Nanosuspension containing particles and extract of natural materials
#68METHOD AND THE USE TO IMPROVE ORAL ABSORPTION OF NICOTINAMIDE AND NICOTINAMIDE RIBOSIDE
#69COMPOSITION AND/OR COMBINATION FOR AQUACULTURE
#70TESTOSTERONE UNDECANOATE COMPOSITIONS
#71Conjugate of polyethylene glycol and anesthetic, and preparation method thereof
#72Abuse-deterrent pharmaceutical compositions of opioids and other drugs
#73Suspension compositions of physiologically active phenolic compounds and methods of making and using the same
#74Abuse-deterrent drug formulations
#75Solid solution compositions and use in chronic inflammation
#76Lipid multiparticulate formulations
#77COMPOSITIONS AND METHODS FOR ENHANCING THE METABOLIC ACTIVITY OR STABILITY OF CURCUMIN
#78ORAL FORMULATIONS OF DEFERASIROX
#79Composition and method for the treatment of menopause
#80Method for economically producing stable and bio-available glutathione
#81METHOD FOR PREPARING NOBLE METAL NANOPARTICLES FROM MYRRH
#82ABUSE-DETERRENT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS
#83Mixed allergen compositions and methods for using the same
#84USE OF FREE RADICAL SCAVENGERS FOR PROTECTING AND TREATING SKIN AND HAIR DAMAGES CAUSED BY CHEMOTHERAPY
#85Food and beverage compositions infused with lipophilic active agents and methods of use thereof
#86Composition for treating or preventing inflammatory skin disease, comprising, as active ingredient, immature citrus fruit extract, or synephrine or salt thereof
#87Food and beverage compositions infused with lipophilic active agents and methods of use thereof
#88Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency
#89Suspension compositions of physiologically active phenolic compounds and methods of making and using the same
#90Magnesium bath salt
#91Extruded chewable formulation comprising bound water
#92NUTRITIONAL AND MEDICINAL ORAL COMPOSITION FOR VETERINARY USE
#93Pain relieving compositions comprising elemental metals
#94Solid solution compositions and use in chronic inflammation
#95Powder composition for disinfection of the teats of dairy animals
#96Bio-available N-acetyl creatine species and compositions thereof
#97Method of making an anhydrous, fat soluble, chewable drug delivery formulation
#98Gelling agent-based dosage form
#99Testosterone undecanoate compositions
#100Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy
#101Tissue engineering construct comprising fibrin
#102Membrane encapsulated nanoparticles and method of use
#103EGCG stabilized gold nanoparticles and method for making same
#104Composition of matter for delivering lipid-soluble materials, and a method for producing it
#105INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
#106Stem Cell Conditioned Medium Compositions
#107TESTOSTERONE UNDECANOATE COMPOSITIONS
#108High-Strength Testosterone Undecanoate Compositions
#109Formulations including digestive enzymes, polysorbate-based surfactants and probiotics
#110INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
#111Use of free radical scavengers for protecting and treating skin and hair damages caused by chemotherapy
#112Compositions comprising elemental metals
#113NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#114NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#115NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#116Abuse-deterrent drug formulations
#117Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics
#118INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS
#119Stabilized, biocompatible gold nanoparticles and enviro-friendly method for making same
#120USE OF FREE RADICAL SCAVENGERS FOR PROTECTING AND TREATING SKIN AND HAIR DAMAGES CAUSED BY CHEMOTHERAPY
#121METHOD OF PRODUCING DRUG-CONTAINING WAX MATRIX PARTICLES, EXTRUDER TO BE USED IN THE METHOD AND SUSTAINED-RELEASE PREPARATION CONTAINING CILOSTAZOL
#122COMPOSITION COMPRISING BIOACTIVE SUBSTANCE
#123METHOD AND COMPOSITION FOR PROVIDING CONTROLLED DELIVERY OF BIOLOGICALLY ACTIVE SUBSTANCES
#124NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#125NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#126Formulations including digestive enzymes and polysorbate surfactants that enhance the colonization of administered probiotics microoganisms
#127NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#128NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORS
#129Coated tablets
#130Injectable nanoparticulate olanzapine formulations
#131Abuse-deterrent drug formulations
#132Method of preparation of mixed phase co-crystals with active agents
#133Sustained release compositions and controlled delivery method
#134Method of making gold nanoparticles capped with extract and treatment method using the same
#135Synthesis of silver nanoparticles from extract
#136Synthesis of silver nanoparticles from seeds